DYRK1A and hepatocellular carcinoma: Therefore, this study not only uncovered the effect of DYRK1A on promoting HCC metastasis and revealed the underlying mechanism but also provided a novel therapeutic approach for improving the prognosis and treatment of patients with metastatic HCC.